Literature DB >> 26889293

Lymphoma relapse presenting as neurolymphomatosis.

My Pham1, Mohammed Awad1.   

Abstract

Neurolymphomatosis (NL) is a rare neurological manifestation of lymphoma characterized by malignant lymphoma cells infiltrating cranial or peripheral nerve, or their roots. We present the first reported Australian case of a patient whose initial presentation of relapsed mantle cell lymphoma was NL. Our case highlights that clinical and imaging findings of NL often mimic other neuropathies, and hence presents unique challenges that may lead to delayed diagnosis and management. We emphasize the importance of considering NL in the differential diagnosis and combining imaging with other diagnostic modalities such as lumbar puncture (LP) to aid in the diagnosis of NL particularly where there is acute neurological deterioration.

Entities:  

Keywords:  Mantle cell lymphoma; neurolymphomatosis; relapse

Year:  2016        PMID: 26889293      PMCID: PMC4732256          DOI: 10.4103/1793-5482.165783

Source DB:  PubMed          Journal:  Asian J Neurosurg


  6 in total

1.  Fusion PET-CT imaging of neurolymphomatosis.

Authors:  A Trojan; M Jermann; C Taverna; T F Hany
Journal:  Ann Oncol       Date:  2002-05       Impact factor: 32.976

2.  Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report.

Authors:  Sigal Grisariu; Batia Avni; Tracy T Batchelor; Martin J van den Bent; Felix Bokstein; David Schiff; Outi Kuittinen; Marc C Chamberlain; Patrick Roth; Anatoly Nemets; Edna Shalom; Dina Ben-Yehuda; Tali Siegal
Journal:  Blood       Date:  2010-04-05       Impact factor: 22.113

3.  A case of neurolymphomatosis involving cranial nerves: MRI and fusion PET-CT findings.

Authors:  Ji Hyun Kim; Jae Hong Jang; Seong-Beom Koh
Journal:  J Neurooncol       Date:  2006-04-28       Impact factor: 4.130

4.  Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab.

Authors:  Hui K Gan; Arun Azad; Lawrence Cher; Paul L R Mitchell
Journal:  Neuro Oncol       Date:  2009-12-24       Impact factor: 12.300

5.  Neurolymphomatosis.

Authors:  Joachim M Baehring; Denise Damek; Emily C Martin; Rebecca A Betensky; Fred H Hochberg
Journal:  Neuro Oncol       Date:  2003-04       Impact factor: 12.300

6.  Neurolymphomatosis on F-18 FDG PET/CT and MRI Findings: A Case Report.

Authors:  Chae Moon Hong; Sang-Woo Lee; Hong Je Lee; Bong Il Song; Hae Won Kim; Sungmin Kang; Shin Young Jeong; Byeong-Cheol Ahn; Jaetae Lee; Yee Soo Chae
Journal:  Nucl Med Mol Imaging       Date:  2010-12-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.